CD11b and CD200 on Circulating Monocytes Differentiate Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

Yousif Subhi1,2, Marie Krogh Nielsen1,2, Christopher Rue Molbech1,2

  • 1Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark.

Insights

Polypoidal choroidal vasculopathy (PCV) shows distinct monocyte profiles, with increased CD11b+ and CD200+ monocytes in type 1 PCV. These findings suggest immunological heterogeneity in PCV linked to vascular network development.

Area of Science:

  • Ophthalmology
  • Immunology
  • Vascular Biology

Background:

  • Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration.
  • Understanding the immunological underpinnings of PCV is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the surface expression of CD11b and CD200 on circulating monocytes in patients with PCV.
  • To compare these monocyte profiles with those in healthy controls and patients with neovascular AMD.
  • To examine differences in monocyte expression between PCV subtypes based on branching vascular network (BVN) presence.

Main Methods:

  • Prospective case-control study involving PCV patients (n=27), healthy controls (n=27), and neovascular AMD patients (n=49).
  • Comprehensive ocular examinations and angiography (fluorescein and indocyanine green) were performed.
  • Flow cytometry analyzed monocyte surface expression of CD11b and CD200 after fluorescent antibody staining.

Main Results:

  • CD11b+ monocytes were elevated in both PCV and neovascular AMD patients.
  • CD200+ and CD11b+CD200+ monocytes were increased in neovascular AMD patients.
  • PCV type 1 (strong BVN) showed significantly higher CD11b+, CD200+, and CD11b+CD200+ monocytes compared to PCV type 2 and controls.

Conclusions:

  • PCV exhibits immunological heterogeneity, with distinct monocyte profiles correlating with angiographic subtypes.
  • Elevated CD11b+ and CD200+ monocytes in PCV type 1 suggest a link between BVN development, retinal injury, and VEGF-mediated processes.
  • Systemic monocyte changes may reflect or drive the progression of PCV.
Abstract

Related Concept Videos